Dr Reddy's has been investing in the areas of access to novel molecules, consumer healthcare and digital therapeutics as additional levers for business growth
Read More
Furthermore, a commercial supply agreement will be signed by the two firms, whereby Ingenus Pharmaceuticals would deliver the product to Dr Reddy's USA
Read More
In the Nifty50 index, 26 stocks ends in the green territory, while 24 stocks advance
Read More
